Trading Insights: Colrain Capital LLC Q2 vs. Q3 2022 13F Holdings Shake-up

Colrain Capital LLC recently released its 13F Holdings for Q2 and Q3 of 2022, and there have been some significant changes in their portfolio. In this article, we'll take a closer look at some of the noteworthy changes that have taken place and what it could mean for investors.

CVS Health Corp. - Up 10.7%

Colrain Capital LLC increased its shareholding in CVS Health Corp. by 4200 shares, totaling 59700, which is equivalent to a 10.7% increase in value, from $5143 thousand in Q2 2022 to $5694 thousand in Q3 2022. CVS Health Corp. is expected to contribute positively to the Colrain portfolio.

Vistra Corp - Down 13.6%

On the other hand, Colrain Capital LLC decreased its holdings in Vistra Corp by 15800 shares, totaling 248100 shares, which is equivalent to a -13.6% decline in value, from $6032 thousand in Q2 2022 to $5210 thousand in Q3 2022. This move by Colrain Capital LLC indicates that the company may have lost confidence in Vistra Corp.'s future performance.

Mosaic - Up 5.8%

Colrain Capital LLC also increased its shareholding in Mosaic by 3050 shares, totaling 94550 shares, which is equivalent to a 5.8% increase in value, from $4321 thousand in Q2 2022 to $4570 thousand in Q3 2022. This might suggest that Colrain Capital LLC sees potential for growth in the company.

Apple - Down 17.9%

One of the most significant decreases in holdings was in Apple, where Colrain Capital LLC reduced its shareholding by 3700 shares, totaling 16050 shares, which is equivalent to a -17.9% decline in value, from $2700 thousand in Q2 2022 to $2218 thousand in Q3 2022. This move by Colrain Capital LLC suggests that the company may have lost faith in Apple's growth prospects.

Medtronic PLC - Down 9.5%

Colrain Capital LLC also decreased its holdings in Medtronic PLC by 100 shares, totaling 19100 shares, which is equivalent to a -9.5% decline in value, from $1718 thousand in Q2 2022 to $1555 thousand in Q3 2022. This decrease could be due to the perceived risks or uncertainty surrounding the company's performance in the future.

Closing thoughts

The 13F Holdings report of Colrain Capital LLC highlights some interesting changes and signals for investors. It is important to keep in mind that the report reflects the snapshot of Colrain's holdings at a specific point in time and that the company's overall portfolio strategy may have changed significantly since then. Nonetheless, this report does provide some valuable insights for investors to consider.